MYOD1 and spindle cell rhabdomyosarcoma: There are a number of other bone and soft tissue tumors which harbor recurrent point mutations including a MYOD1 p.L122R mutation in a large percentage of spindle cell rhabdomyosarcoma 16, 17, an exceptionally rare, and aggressive high‐grade tumor.